Curt H. LaBelle - 10 Jan 2022 Form 3 Insider Report for REVELATION BIOSCIENCES, INC. (REVB)

Role
Director
Signature
/s/ J.P. Galda, as attorney-in-fact for Curt H LaBelle
Issuer symbol
REVB
Transactions as of
10 Jan 2022
Net transactions value
$0
Form type
3
Filing time
20 Jan 2022, 17:01:28 UTC
Previous filing
22 Nov 2021
Next filing
18 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding REVB Restricted Stock Unit 10 Jan 2022 Common Stock 21,422 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These RSUs vest quarterly over a one-year period, with the first quarterly vesting scheduled to occur on May 23, 2021.
F2 RSUs do not expire; they either vest or are canceled prior to vesting date.
F3 Each RSU converts into common stock on a one-for-one basis.

Remarks:

Exhibit 24 - Power of Attorney.